Rang	Name	Position
1	Dr. Ramy Farid Ph.D.	CEO, President & Director
2	Dr. Karen Akinsanya Ph.D.	President, Head of Therapeutics R&D and Chief Strategy Officer & Partnerships
3	Dr. Richard A. Friesner Ph.D.	Co-Founder, Scientific Advisory Chairman and Director
4	Mr. Richie Jain	Executive VP, CFO & Treasurer
5	Ms. Yvonne Tran Esq.	Corporate Secretary, Chief Legal & People Officer
6	Prof. William Goddard III, Ph.D.	Co-Founder & Scientific Advisor
7	Mr. Kenneth Patrick Lorton	Executive VP, CTO & COO of Software
8	Ms. Therese Abrams	Principal Accounting Officer
9	Mr. Shane Brauner	Executive VP & Chief Information Officer
10	Ms. Jaren Irene Madden	Chief Corporate Affairs Officer & Head of Investor Relations

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	0,00%	0,00 Mio. USD
2	Gates Bill & Melinda Foundation	0,00%	0,00 Mio. USD
3	Vanguard Group Inc	0,00%	0,00 Mio. USD
4	Rubric Capital Management LP	0,00%	0,00 Mio. USD
5	Vanguard Portfolio Management, LLC	0,00%	0,00 Mio. USD
6	Amova Asset Management Americas, Inc	0,00%	0,00 Mio. USD
7	Sumitomo Mitsui Trust Group Inc	0,00%	0,00 Mio. USD
8	Massachusetts Financial Services Company	0,00%	0,00 Mio. USD
9	UBS Asset Mgmt Americas Inc	0,00%	0,00 Mio. USD
10	Vanguard Capital Management, LLC	0,00%	0,00 Mio. USD
11	State Street Corp	0,00%	0,00 Mio. USD
12	ARK Investment Management LLC	0,00%	0,00 Mio. USD
13	Morgan Stanley - Brokerage Accounts	0,00%	0,00 Mio. USD
14	Geode Capital Management, LLC	0,00%	0,00 Mio. USD
15	UBS Group AG	0,00%	0,00 Mio. USD
16	Dimensional Fund Advisors, Inc.	0,00%	0,00 Mio. USD
17	Baillie Gifford & Co Limited.	0,00%	0,00 Mio. USD
18	The Goldman Sachs Group Inc	0,00%	0,00 Mio. USD
19	Man Group PLC	0,00%	0,00 Mio. USD
20	Northern Trust Corp	0,00%	0,00 Mio. USD